SN BioScience
Seongnam
About SN BioScience
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubility or delivery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2020)
- Website: snbioscience.com
- Phone: +82-32-818-9925
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/sn-bioscience-34490 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.